Heart rate variability in anaesthesiology – narrative review

Autor: Magdalena Wujtewicz, Radoslaw Owczuk

Publikováno v: Anaesthesiology Intensive Therapy, Vol 55, Iss 1, Pp 1-8 (2023)

Heart rate variability (HRV) is a measure that shows the variation in time between consecutive heartbeats – a physiological phenomenon controlled by the autonomic nervous system. Over the years the analysis of this parameter has been used in many f

Externí odkaz: https://doaj.org/article/583aef1b100741a7ac4ca9bae1d9cc47

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Positive Relationship Between Precompetitive Sympathetic Predominance and Competitive Performance in Elite Extreme Sports Athletes

Autor: Seiji Matsumura, Ken Watanabe, Naoki Saijo, Yuuki Ooishi, Toshitaka Kimura, Makio Kashino

Publikováno v: Frontiers in Sports and Active Living, Vol 3 (2021)

Elite athletes achieve superior performance under high pressure in competitive situations. Although it is known that such situations affect the precompetitive activity of their autonomic nervous system (ANS), the relationship between precompetitive A

Externí odkaz: https://doaj.org/article/13d72e95f58e4986b342b21290aee542

Psychological and Antibacterial Effects of Footbath Using the Lindera umbellata Essential Oil

Autor: Maiko Kitajima, Marika Miura, Naoki Nanashima, Toshiko Tomisawa, Shizuka Takamagi, Miyuki Fujioka, Naoya In, Tomohiro Osanai

Publikováno v: Molecules, Vol 26, Iss 17, p 5128 (2021)

Lindera umbellata (Lu) essential oil primarily contains linalool and has relaxation properties. We investigated the psychological and antibacterial effects of footbath with Lu essential oil. The participants included 20 women without medical history

Externí odkaz: https://doaj.org/article/d86c7f6daf554859b683cb5bcfba00f2

Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial

Autor: Rosalie A. Scholtes, Charlotte M. Mosterd, Anne C. Hesp, Mark M. Smits, Hiddo J. L. Heerspink, Daniël H. van Raalte

Publikováno v: Scholtes, R A, Mosterd, C M, Hesp, A C, Smits, M M, Heerspink, H J L & van Raalte, D H 2023, ' Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes : A secondary analysis of a randomized crossover trial ', Diabetes, Obesity and Metabolism, vol. 25, no. 1, pp. 198-207 . https://doi.org/10.1111/dom.14864
Diabetes, Obesity and Metabolism, 25(1), 198-207. Wiley
Diabetes, Obesity and Metabolism, 25(1), 198-207. Wiley-Blackwell

Aim: To study the effects of the sodium-glucose co-transporter-2 (SGLT2) inhibitor empagliflozin, the angiotensin receptor blocker (ARB) losartan, and their combination on blood pressure, while studying the mechanisms potentially involved.Methods: A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26bb531f561601207a504a8074f4591a
https://doi.org/10.1111/dom.14864